Induced Pluripotent Stem Cells for Clinical Application; the working alternative for Embryonic Stem Cells?

Just like the gold rush back in the 1840s, people fawn over stem cells, which are thought to be the potential miracle drug for Alzheimer’s disease, spinal cord injuries, heart disease, and other diseases. The earliest developed stem cell and the most efficient one to produce is the embryonic stem cell. Many research in embryonic stem cells have reached the clinical trial phase, with mixed results for success rate. Despite the questionable efficacy of embryonic stem cell therapy, many people are willing to use that option with extravagant cost. Throughout the years however, the spotlight has shifted towards a new type of stem cells; the induced pluripotent stem cells (iPS Cells). On